Browsing Tag
Europe
151 posts
EVE Energy achieves world’s first 400MWh energy storage project with 628Ah ultra-large cells
EVE Energy achieves a world-first 400MWh grid project with 628Ah ultra-large cells, marking the big-battery era. Find out what this means for storage markets.
Pulnovo Medical secures dual IDE approvals with CMS backing to advance PADN clinical trials in the U.S.
Pulnovo Medical gains FDA IDE and CMS coverage to launch PADN U.S. trials, signaling disruption in the pulmonary hypertension device market.
Why Avanzanite’s hire of Dr. Mark Bechter could reshape how orphan drugs reach patients across 32 countries
Avanzanite Bioscience hires Dr. Mark Bechter as SVP medical affairs to drive rare disease growth, with H1 2025 revenues tripling. Learn more.
Sirtex secures expanded CE Mark approval for SIR-Spheres Y-90 resin microspheres in Europe, widening access to liver cancer treatment
Sirtex secures CE Mark expansion for SIR-Spheres Y-90 in Europe, unlocking wider access to liver cancer patients and reinforcing its oncology leadership.
Can Fiserv’s AIB Merchant Services buyout give Clover the edge in Europe’s POS war?
Fiserv acquires full ownership of AIB Merchant Services to fuel Clover’s European expansion. Find out how this move could reshape the region’s POS market.
AI SPERA’s Criminal IP enters European cybersecurity market amid rising ransomware risks
Criminal IP enters Europe via DotForce to offer AI-powered threat intelligence and attack surface management. Learn how the platform aims to reshape cyber defense.
From diplomacy to quantum tech: Jesper Kamp joins Atom Computing to expand European reach
Find out how Atom Computing’s Europe expansion is accelerating with Jesper Kamp’s appointment and Denmark’s growing role in the global quantum ecosystem.
Huspy secures $59m Series B to fuel expansion across Europe and Saudi Arabia
Discover how Huspy’s $59M Series B round, led by Balderton Capital, is driving its European and Middle Eastern real estate tech growth—read more now.
argenx wins EU approval for subcutaneous VYVGART in CIDP, ending 30-year innovation drought in treatment
argenx gains EU approval for subcutaneous VYVGART in CIDP, reshaping autoimmune neurology care with a novel self-injection biologic.
Experian and AWS deepen strategic partnership to scale generative AI and real-time credit analytics
Experian deepens its AWS partnership to scale generative AI, accelerate real-time credit analytics, and migrate legacy infrastructure. Learn what this means.